Published in Sci Transl Med on November 09, 2011
Integrated morphologic analysis for the identification and characterization of disease subtypes. J Am Med Inform Assoc (2012) 2.68
Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma. Cell Cycle (2013) 1.52
Identification of tumor epithelium and stroma in tissue microarrays using texture analysis. Diagn Pathol (2012) 1.23
The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities. Mol Oncol (2012) 1.21
Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier. Genome Biol (2014) 1.11
Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data. J Am Med Inform Assoc (2013) 1.10
Breast cancer in young women. Nat Rev Clin Oncol (2012) 1.07
Nuclear morphometric analysis (NMA): screening of senescence, apoptosis and nuclear irregularities. PLoS One (2012) 1.04
Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology. Lab Invest (2015) 0.98
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features. Nat Commun (2016) 0.98
Mining genome sequencing data to identify the genomic features linked to breast cancer histopathology. J Pathol Inform (2014) 0.97
A quantitative histomorphometric classifier (QuHbIC) identifies aggressive versus indolent p16-positive oropharyngeal squamous cell carcinoma. Am J Surg Pathol (2014) 0.95
Computer-based image studies on tumor nests mathematical features of breast cancer and their clinical prognostic value. PLoS One (2013) 0.94
Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images. Lab Invest (2015) 0.94
C-path: a Watson-like visit to the pathology lab. Sci Transl Med (2011) 0.92
Complex biomarker discovery in neuroimaging data: Finding a needle in a haystack. Neuroimage Clin (2013) 0.91
Deep learning for digital pathology image analysis: A comprehensive tutorial with selected use cases. J Pathol Inform (2016) 0.90
[Epithelial-mesenchymal transition in non-small cell lung cancer]. Pathologe (2012) 0.90
MRI enhancement in stromal tissue surrounding breast tumors: association with recurrence free survival following neoadjuvant chemotherapy. PLoS One (2013) 0.90
Fast and accurate automated cell boundary determination for fluorescence microscopy. Sci Rep (2013) 0.89
Computational pathology to discriminate benign from malignant intraductal proliferations of the breast. PLoS One (2014) 0.88
Emerging Themes in Image Informatics and Molecular Analysis for Digital Pathology. Annu Rev Biomed Eng (2016) 0.88
Identifying survival associated morphological features of triple negative breast cancer using multiple datasets. J Am Med Inform Assoc (2013) 0.86
A Deep Convolutional Neural Network for segmenting and classifying epithelial and stromal regions in histopathological images. Neurocomputing (2016) 0.86
Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity. Sci Rep (2016) 0.85
Assessment of tumour viability in human lung cancer xenografts with texture-based image analysis. J Clin Pathol (2015) 0.85
GRAPHIE: graph based histology image explorer. BMC Bioinformatics (2015) 0.84
Extensive rewiring of epithelial-stromal co-expression networks in breast cancer. Genome Biol (2015) 0.84
Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer. Breast Cancer Res (2013) 0.83
Benign breast tissue composition in breast cancer patients: association with risk factors, clinical variables, and gene expression. Cancer Epidemiol Biomarkers Prev (2014) 0.83
Development of DNA damage response signaling biomarkers using automated, quantitative image analysis. J Histochem Cytochem (2013) 0.83
Transcription factor networks in invasion-promoting breast carcinoma-associated fibroblasts. Cancer Microenviron (2012) 0.83
Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. J Pathol Clin Res (2014) 0.83
Diagnostic assessment of osteosarcoma chemoresistance based on Virtual Clinical Trials. Med Hypotheses (2015) 0.82
Stromal expression of miR-21 identifies high-risk group in triple-negative breast cancer. Am J Pathol (2014) 0.82
The future of genomics in pathology. F1000 Med Rep (2012) 0.82
Quantifying local heterogeneity via morphologic scale: Distinguishing tumoral from stromal regions. J Pathol Inform (2013) 0.82
Improving prediction of prostate cancer recurrence using chemical imaging. Sci Rep (2015) 0.82
Software: The computer will see you now. Nature (2013) 0.81
Computer-based image analysis in breast pathology. J Pathol Inform (2016) 0.81
Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer. Br J Cancer (2014) 0.81
Crowdsourcing image annotation for nucleus detection and segmentation in computational pathology: evaluating experts, automated methods, and the crowd. Pac Symp Biocomput (2015) 0.81
Localization of Diagnostically Relevant Regions of Interest in Whole Slide Images: a Comparative Study. J Digit Imaging (2016) 0.81
Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives. Gut (2014) 0.80
A texture based pattern recognition approach to distinguish melanoma from non-melanoma cells in histopathological tissue microarray sections. PLoS One (2013) 0.80
New breast cancer prognostic factors identified by computer-aided image analysis of HE stained histopathology images. Sci Rep (2015) 0.80
Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res (2016) 0.80
Automated objective determination of percentage of malignant nuclei for mutation testing. Appl Immunohistochem Mol Morphol (2014) 0.79
Computational Pathology: A Path Ahead. Arch Pathol Lab Med (2015) 0.79
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis. J Thorac Oncol (2016) 0.79
Automated Tubule Nuclei Quantification and Correlation with Oncotype DX risk categories in ER+ Breast Cancer Whole Slide Images. Sci Rep (2016) 0.78
Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis. PLoS Med (2016) 0.78
Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: interdisciplinary approaches. Breast Dis (2014) 0.78
Empirical comparison of color normalization methods for epithelial-stromal classification in H and E images. J Pathol Inform (2016) 0.78
c-Cbl mediates the degradation of tumorigenic nuclear β-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors. Oncotarget (2016) 0.77
Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3(+) Tregs in follicular lymphoma. Br J Cancer (2015) 0.76
High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype. Clin Cancer Res (2016) 0.76
Quantification of the heterogeneity of prognostic cellular biomarkers in ewing sarcoma using automated image and random survival forest analysis. PLoS One (2014) 0.76
Real-time interactive data mining for chemical imaging information: application to automated histopathology. BMC Bioinformatics (2013) 0.76
A model of the spatial tumour heterogeneity in colorectal adenocarcinoma tissue. BMC Bioinformatics (2016) 0.76
An unsupervised MVA method to compare specific regions in human breast tumor tissue samples using ToF-SIMS. Analyst (2016) 0.76
Quantitative diagnosis of breast tumors by morphometric classification of microenvironmental myoepithelial cells using a machine learning approach. Sci Rep (2017) 0.75
Novel histopathologic feature identified through image analysis augments stage II colorectal cancer clinical reporting. Oncotarget (2016) 0.75
Robust automatic breast cancer staging using a combination of functional genomics and image-omics. Conf Proc IEEE Eng Med Biol Soc (2015) 0.75
A robust nonlinear tissue-component discrimination method for computational pathology. Lab Invest (2016) 0.75
A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients. Sci Data (2017) 0.75
Quantitative assessment of pancreatic cancer precursor lesions in IHC-stained tissue with a tissue image analysis platform. Lab Invest (2016) 0.75
Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics. Oncoimmunology (2016) 0.75
Emerging Tools for Computer-Aided Diagnosis and Prognostication. J Clin Trials (2014) 0.75
Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer. Sci Rep (2016) 0.75
Characterising the tumour morphological response to therapeutic intervention: an ex vivo model. Dis Model Mech (2012) 0.75
INTEGRATIVE ANALYSIS FOR LUNG ADENOCARCINOMA PREDICTS MORPHOLOGICAL FEATURES ASSOCIATED WITH GENETIC VARIATIONS. Pac Symp Biocomput (2016) 0.75
Crowdsourcing for translational research: analysis of biomarker expression using cancer microarrays. Br J Cancer (2016) 0.75
Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent. Sci Rep (2017) 0.75
Invasive ductal breast carcinoma detector that is robust to image magnification in whole digital slides. J Med Imaging (Bellingham) (2016) 0.75
Development of a practical spatial-spectral analysis protocol for breast histopathology using Fourier transform infrared spectroscopic imaging. Faraday Discuss (2016) 0.75
Prostate Cancer: A Correlative Study of Multiparametric MR Imaging and Digital Histopathology. Radiology (2017) 0.75
histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. Nat Methods (2017) 0.75
Sparse Contribution Feature Selection and Classifiers Optimized by Concave-Convex Variation for HCC Image Recognition. Biomed Res Int (2017) 0.75
Automated Classification of Benign and Malignant Proliferative Breast Lesions. Sci Rep (2017) 0.75
Artificial intelligence for analyzing orthopedic trauma radiographs. Acta Orthop (2017) 0.75
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
Population genomics of human gene expression. Nat Genet (2007) 24.49
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA (2006) 24.01
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature (2010) 23.55
Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol (2009) 22.22
A gene-coexpression network for global discovery of conserved genetic modules. Science (2003) 18.75
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res (2004) 16.51
Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet (2003) 14.56
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer. Cancer Cell (2007) 11.21
Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A (2004) 10.99
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst (2009) 10.91
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A (2005) 10.85
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol (2004) 9.38
A module map showing conditional activity of expression modules in cancer. Nat Genet (2004) 8.57
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. N Engl J Med (2016) 8.53
The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science (2008) 8.52
Genes that mediate breast cancer metastasis to the brain. Nature (2009) 8.23
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res (2008) 8.12
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res (2008) 7.39
Molecular characterisation of soft tissue tumours: a gene expression study. Lancet (2002) 7.05
Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A (2002) 6.98
Metastatic behavior of breast cancer subtypes. J Clin Oncol (2010) 6.17
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst (2011) 6.11
Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med (2006) 6.04
Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol (2011) 5.72
Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol (2010) 5.44
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med (2008) 5.19
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature (2010) 5.05
deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput Biol (2011) 4.66
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial. J Clin Oncol (2009) 4.66
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clin Cancer Res (2010) 4.61
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res (2007) 4.41
From signatures to models: understanding cancer using microarrays. Nat Genet (2005) 4.29
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A (2012) 4.20
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer. J Clin Oncol (2012) 4.14
Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A (2003) 3.98
Genetic regulators of large-scale transcriptional signatures in cancer. Nat Genet (2006) 3.96
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A (2009) 3.87
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol (2004) 3.84
Identifying regulatory mechanisms using individual variation reveals key role for chromatin modification. Proc Natl Acad Sci U S A (2006) 3.68
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. J Clin Oncol (2006) 3.42
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER). Lancet Oncol (2007) 3.32
Learning a prior on regulatory potential from eQTL data. PLoS Genet (2009) 3.31
Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies. Science (2013) 3.25
Functional organization of the S. cerevisiae phosphorylation network. Cell (2009) 3.15
Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol (2002) 3.11
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer (2007) 3.09
MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res (2011) 3.02
Sfp1 is a stress- and nutrient-sensitive regulator of ribosomal protein gene expression. Proc Natl Acad Sci U S A (2004) 2.99
Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol (2009) 2.96
A DNA microarray survey of gene expression in normal human tissues. Genome Biol (2005) 2.90
Determination of stromal signatures in breast carcinoma. PLoS Biol (2005) 2.84
Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res (2013) 2.77
Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science (2014) 2.77
AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest (2006) 2.74
Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A (2006) 2.72
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol (2008) 2.68
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U S A (2008) 2.64
Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol (2003) 2.59
Gene expression patterns in ovarian carcinomas. Mol Biol Cell (2003) 2.55
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis. Mod Pathol (2007) 2.47
An international Ki67 reproducibility study. J Natl Cancer Inst (2013) 2.46
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers. J Clin Oncol (2008) 2.38
A protein domain-based interactome network for C. elegans early embryogenesis. Cell (2008) 2.23
Opportunities for improving the therapeutic ratio for patients with sarcoma. Lancet Oncol (2007) 2.23
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. Clin Cancer Res (2007) 2.22
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index. Clin Cancer Res (2006) 2.16
Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol (2012) 2.12
Integration of early physiological responses predicts later illness severity in preterm infants. Sci Transl Med (2010) 2.12
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer. Breast Cancer Res (2012) 2.11
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer. Breast Cancer Res (2008) 2.09
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A (2006) 2.08
[Categorization of occult tumour cells in lymph nodes in patients with colon cancer not reliable enough]. Ned Tijdschr Geneeskd (2011) 2.03
PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. BMC Med Genomics (2012) 2.01
The macrophage colony-stimulating factor 1 response signature in breast carcinoma. Clin Cancer Res (2009) 2.00
Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics. Cancer Cell (2012) 1.99
The Stanford Tissue Microarray Database. Nucleic Acids Res (2007) 1.96
Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc Natl Acad Sci U S A (2013) 1.94
TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol (2007) 1.94
3'-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS One (2010) 1.91
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss. Mod Pathol (2008) 1.90